Mesenchymal Stem Cells (MSC) for the amelioration of ischaemia-reperfusion injury (IRI) after deceased donor renal transplantation, a phase 1 pilot study

Phase 1

Recruiting

• Conditions: Kidney Transplantation; Ischaemia reperfusion injury; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12615000678594
• Lead Sponsor: Royal Perth Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-06-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Adult Deceased Donor kidney recipients

Exclusion Criteria

Live Kidney Donor Recipients

Study & Design

• Study Type: Interventional
• Study Design: Not specified